Seizure drug for mito patients begins clinical trials in UK

Welcome to our first newsletter of 2022!

We're delighted to bring you positive news about an exciting drug study happening in the UK that could benefit mito patients affected by seizures. Linking drugs companies to the patient groups they depend on to conduct their research is one of our charity's most important roles, along with educating and informing patients about clinical trials that might be relevant to their disease. As Matthew Klein of PTC Therapeutics says in our interview, this is a hard mountain to climb, and we'll only get there by working together.

Enjoy the read, and thank you for your continued support!